EP3672595
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.7.2019:
21.7.2021:
19843524.0
:
21.7.2039
:
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
22.7.2019
21.7.2021
:
Ascentage Pharma (Suzhou) Co., Ltd.:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, CN
:
YANG, Dajun:
Suzhou, Jiangsu 215000, CN
:
ZHAI, Yifan:
Suzhou, Jiangsu 215000, CN
:
WANG, Guangfeng:
Suzhou, Jiangsu 215000, CN
:
201810862169:
31.7.2018:
CN
:
CN2019097081:
22.7.2019
:
A61K 31/4745, A61K 31/496, A61K 31/497, A61K 31/00, A61P 35/00, A61P 35/02, A61K 31/635, A61K 9/00, A61K 9/16, A61K 9/20, A61K 9/48, A61K 45/06, C07D 471/04